Increasing salinity of fibrinogen solvent generates stable fibrin hydrogels for cell delivery or tissue engineering

• Published in: PloS one 2021-05, Vol.16 (5), p.e0239242-e0239242
• Main Authors: Jarrell, Dillon K, Vanderslice, Ethan J, Lennon, Mallory L, Lyons, Anne C, VeDepo, Mitchell C, Jacot, Jeffrey G
• Format: Article
• Language: English
• Subjects: Amniotic fluid; Analysis; Angiogenesis; Biocompatibility; Bioengineering; Biological activity; Biology and Life Sciences; Cell culture; Cell differentiation; Data analysis; Degradation; Editing; Engineering and Technology; Fibrin; Fibrinogen; Fibrinolysis; Fibroblasts; Funding; Gels; Glues; Hydrogels; Inhibitors; Measurement; Morphology; Pediatrics; Physical Sciences; Plasmin; Polymerization; Reviews; Salinity; Salt; Stem cells; Surgical implants; Tissue engineering
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0239242

Fibrin has been used clinically for wound coverings, surgical glues, and cell delivery because of its affordability, cytocompatibility, and ability to modulate angiogenesis and inflammation. However, its rapid degradation rate has limited its usefulness as a scaffold for 3D cell culture and tissue engineering. Previous studies have sought to slow the degradation rate of fibrin with the addition of proteolysis inhibitors or synthetic crosslinkers that require multiple functionalization or polymerization steps. These strategies are difficult to implement in vivo and introduce increased complexity, both of which hinder the use of fibrin in research and medicine. Previously, we demonstrated that additional crosslinking of fibrin gels using bifunctionalized poly(ethylene glycol)-n-hydroxysuccinimide (PEG-NHS) slows the degradation rate of fibrin. In this study, we aimed to further improve the longevity of these PEG-fibrin gels such that they could be used for tissue engineering in vitro or in situ without the need for proteolysis inhibitors. It is well documented that increasing the salinity of fibrin precursor solutions affects the resulting gel morphology. Here, we investigated whether this altered morphology influences the fibrin degradation rate. Increasing the final sodium chloride (NaCl) concentration from 145 mM (physiologic level) to 250 mM resulted in fine, transparent high-salt (HS) fibrin gels that degrade 2-3 times slower than coarse, opaque physiologic-salt (PS) fibrin gels both in vitro (when treated with proteases and when seeded with amniotic fluid stem cells) and in vivo (when injected subcutaneously into mice). Increased salt concentrations did not affect the viability of encapsulated cells, the ability of encapsulated endothelial cells to form rudimentary capillary networks, or the ability of the gels to maintain induced pluripotent stem cells. Finally, when implanted subcutaneously, PS gels degraded completely within one week while HS gels remained stable and maintained viability of seeded dermal fibroblasts. To our knowledge, this is the simplest method reported for the fabrication of fibrin gels with tunable degradation properties and will be useful for implementing fibrin gels in a wide range of research and clinical applications.